Allergan Promo For Acular LS Broadens Indications, FDA Warning Letter Says
This article was originally published in The Pink Sheet Daily
Executive SummaryJournal ad for the ophthalmic misleadingly suggests the drug is indicated for phacoemulsification, according to FDA.
You may also be interested in...
The eighth enforcement letter from FDA in a decade cites the company for unjustified claims about its seasonal allergic rhinitis drug, Patanase.